Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2010-01-12

Clinical Trial Update: Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports heart rate changes in patients with schizophrenia or bipolar disorder treated with aripiprazole or quetiapine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)
  • Quetiapine (quetiapine)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Schizophrenia, Bipolar | Phase 4 | Status: UNKNOWN